Table 1.
Patient | PMN | Lymph | Plasma donor ratio | Diagnosis | Status |
---|---|---|---|---|---|
1 | 100 | 100 | 30 | AML | Death in remission |
2 | 100 | 100 | 38.8 | CML | BCR-ABL: 0.56 |
3 | 100 | 100 | 52.5 | CML | BCR-ABL: 3.7 |
4 | 100 | 100 | 57 | AML | EM disease |
5 | 100 | 100 | 60 | CML | BCR-ABL: 0.003 |
6 | 100 | 100 | 64.5 | ALL | Relapse |
7 | 100 | 100 | 66.9 | AML | Relapse |
8 | 100 | 100 | 68.4 | ALL | FISH 3% monosomy 17 |
9 | 100 | 100 | 69.4 | ALL | Relapse |
10 | 100 | 100 | 74.4 | CML | CR |
11 | 100 | 100 | 75 | CML | BCR-ABL: 0.03 |
12 | 100 | 100 | 76 | AML | CR |
13 | 100 | 100 | 76.2 | ALL | 10% by FISH t(1; 19) |
14 | 100 | 100 | 76.5 | ALL | CR |
15 | 100 | 100 | 78.3 | CML | BCR-ABL: 3.57 one month earlier |
16 | 100 | 100 | 79.9 | ALL | CR |
17 | 100 | 100 | 80 | AML | CR |
18 | 100 | 100 | 80 | AML | CR |
19 | 100 | 100 | 80 | ALL | CR |
20 | 100 | 100 | 81.7 | ALL | CR |
21 | 100 | 100 | 82 | AML | CR |
22 | 100 | 100 | 82.4 | AML | CR |
23 | 100 | 100 | 84.3 | AML | Relapse |
24 | 100 | 100 | 84.6 | AML | CR |
25 | 100 | 100 | 84.7 | AML | CR |
26 | 100 | 100 | 88.1 | ALL | CR |
27 | 100 | 100 | 88.4 | ALL | EM disease |
28 | 100 | 100 | 89.3 | AML | CR |
29 | 100 | 100 | 89.4 | AML | CR |
30 | 100 | 100 | 90 | CML | CR |
31 | 100 | 100 | 90 | AML | Relapse |
32 | 100 | 100 | 90 | ALL | CR |
33 | 100 | 100 | 90 | ALL | CR |
34 | 100 | 100 | 90 | AML | CR |
PMN: polymorphonuclear cells; EM: extramedullary.